{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:01:36Z","timestamp":1784894496507,"version":"3.55.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Leukemic patients are prone to infectious agents such as viruses due to dysregulated immune system resulting from infiltration of the bone marrow by malignant cells, chronic stimulation, reactivation of some viruses and viral pathogenicity as well as rarely from acquisition of a new infections leading to severe complications. However, the prevalence of these infections has not been systematically documented in resource-limited settings such as Ethiopia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To determine the prevalence of HBV, HCV, and HIV among adult and adolescent in-patients with acute leukemia before the administration of chemotherapy, at the Tikur Anbessa Specialized Hospital (TASH) in Addis Ababa, Ethiopia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross sectional study was conducted on 176 adult and adolescent inpatient Ethiopians, who were diagnosed with acute leukemia from April 2019 to June 2021. Socio-demographic characteristics and relevant clinical data were collected. Peripheral blood samples were collected and tested for HBV, HIV, and HCV using Enzyme-Linked Immunosorbent Assay (ELISA) and real-time PCR. Chi-square tests were used to assess associations between variables.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 176 patients, 109(62%) were males. The median age was 25[IQR,18\u201335] yr, with a range from 13 to 76\u00a0year. The prevalence of HBV (positivity for HBsAg plus HBV DNA), HCV and HIV was 21.6%, 1.7%, and 1.7%, respectively. HBsAg was positive in 19 cases (10.8%). Among 157 HBsAg negative patients, 52(33.1%) were positive for Anti-HBcAg; of these seropositive cases, 47.5% were positive for HBV DNA. Most DNA positive, HBsAg negative cases (79.0%) had DNA concentrations below 200 IU\/ml indicating true occult HBV infection (OBI). Of the 176 cases, 122 had a history of blood transfusions, but no statistically significant association was found between HBV infection and blood product transfusion history (P\u2009=\u20090.963).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The prevalence of HBV, HIV and HCV in patients with acute leukemia was similar to the national prevalence level of these infections. Given the HBsAg positivity and the high prevalence of occult hepatitis B infection in our study, these patients may be at increased risk for chemotherapy related hepatitis flares. Hence, clinicians caring these patients are strongly advised to screen their patients for HBV and also for HIV and HCV infections routinely.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13027-023-00519-6","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T16:01:53Z","timestamp":1689177713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Frequency of viral infections in adolescent and adult in-patient Ethiopians with acute leukemia at presentation to a tertiary care teaching hospital: a cross-sectional study"],"prefix":"10.1186","volume":"18","author":[{"given":"Jemal","family":"Alemu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balako","family":"Gumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aster","family":"Tsegaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz","family":"Abubeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fisihatsion","family":"Tadesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Shewaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyada","family":"Rahimeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adane","family":"Mihret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andargachew","family":"Mulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amha","family":"Gebremedhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawleigh","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"key":"519_CR1","doi-asserted-by":"crossref","unstructured":"Fiegl M. Epidemiology, pathogenesis, and etiology of acute leukemia. Handbook of acute leukemia. Springer; 2016. pp. 3\u201313.","DOI":"10.1007\/978-3-319-26772-2_2"},{"key":"519_CR2","doi-asserted-by":"crossref","unstructured":"Chandran R, Hakki M, Spurgeon S. Infections in leukemia. Sepsis-An Ongoing and Significant Challenge. 2012:334 \u2013 68.","DOI":"10.5772\/50193"},{"issue":"9","key":"519_CR3","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1038\/leu.2014.108","volume":"28","author":"MH Andersen","year":"2014","unstructured":"Andersen MH. The targeting of immunosuppressive mechanisms in hematological malignancies. Leukemia. 2014;28(9):1784\u201392.","journal-title":"Leukemia"},{"issue":"4suppl","key":"519_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/107327481502204s02","volume":"22","author":"L Balducci","year":"2015","unstructured":"Balducci L, Dolan D. Chronic lymphocytic leukemia in the elderly: epidemiology and proposed patient-related approach. Cancer Control. 2015;22(4suppl):3\u20136.","journal-title":"Cancer Control"},{"issue":"6","key":"519_CR5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.blre.2018.04.007","volume":"32","author":"BW Teh","year":"2018","unstructured":"Teh BW, Tam CS, Handunnetti S, Worth LJ, Slavin MA. Infections in patients with chronic lymphocytic leukaemia: mitigating risk in the era of targeted therapies. Blood Rev. 2018;32(6):499\u2013507.","journal-title":"Blood Rev"},{"issue":"8","key":"519_CR6","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/cid\/cir492","volume":"53","author":"A Safdar","year":"2011","unstructured":"Safdar A, Armstrong D. Infections in patients with hematologic neoplasms and hematopoietic stem cell transplantation: neutropenia, humoral, and splenic defects. Clin Infect Dis. 2011;53(8):798\u2013806.","journal-title":"Clin Infect Dis"},{"issue":"Suppl2","key":"519_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/leusup.2012.15","volume":"1","author":"A Busca","year":"2012","unstructured":"Busca A. Viral infections in patients with hematological malignancies. Leuk supplements. 2012;1(Suppl2):24\u20135.","journal-title":"Leuk supplements"},{"issue":"7","key":"519_CR8","doi-asserted-by":"publisher","first-page":"e0180416","DOI":"10.1371\/journal.pone.0180416","volume":"12","author":"B Biadgo","year":"2017","unstructured":"Biadgo B, Shiferaw E, Woldu B, Alene KA, Melku M. Transfusion-transmissible viral infections among blood donors at the north Gondar district blood bank, northwest Ethiopia: a three year retrospective study. PLoS ONE. 2017;12(7):e0180416.","journal-title":"PLoS ONE"},{"issue":"11","key":"519_CR9","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1158\/1055-9965.EPI-08-0408","volume":"17","author":"LA Anderson","year":"2008","unstructured":"Anderson LA, Pfeiffer R, Warren JL, Landgren O, Gadalla S, Berndt SI, et al. Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomarkers Prev. 2008;17(11):3069\u201375.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"519_CR10","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/j.1349-7006.2004.tb03256.x","volume":"95","author":"K Matsuo","year":"2004","unstructured":"Matsuo K, Kusano A, Sugumar A, Nakamura S, Tajima K, Mueller NE. Effect of hepatitis C virus infection on the risk of non-hodgkin\u2019s lymphoma: a meta\u2010analysis of epidemiological studies. Cancer Sci. 2004;95(9):745\u201352.","journal-title":"Cancer Sci"},{"issue":"6","key":"519_CR11","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/jmv.21168","volume":"80","author":"SC Park","year":"2008","unstructured":"Park SC, Jeong SH, Kim J, Han CJ, Kim YC, Choi KS, et al. High prevalence of hepatitis B virus infection in patients with B-cell non\u2010Hodgkin\u2019s lymphoma in Korea. J Med Virol. 2008;80(6):960\u20136.","journal-title":"J Med Virol"},{"issue":"8","key":"519_CR12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1023\/A:1007420725704","volume":"13","author":"E Kocabas","year":"1997","unstructured":"Kocabas E, Aksaray N, Alhan E, Tanyeli A, Koksal F, Yarkin F. Hepatitis B and C virus infections in turkish children with cancer. Eur J Epidemiol. 1997;13(8):869\u201373.","journal-title":"Eur J Epidemiol"},{"key":"519_CR13","unstructured":"Tikur Anbessa Specialized Hospital (TASH). 2023. http:\/\/www.aau.edu.et\/chs\/tikur-anbessa-specialized-hospital\/background-of-tikur-anbessa-hospital.Accessed 8 Apr 2023."},{"key":"519_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00277-015-2325-z","volume":"94","author":"B Chereda","year":"2015","unstructured":"Chereda B, Melo JV. Natural course and biology of CML. Ann Hematol. 2015;94:107\u201321.","journal-title":"Ann Hematol"},{"issue":"7","key":"519_CR15","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1172\/JCI41246","volume":"120","author":"D Perrotti","year":"2010","unstructured":"Perrotti D, Jamieson C, Goldman J, Skorski T. Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Investig. 2010;120(7):2254\u201364.","journal-title":"J Clin Investig"},{"key":"519_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-016-2090-1","volume":"16","author":"Y Belyhun","year":"2016","unstructured":"Belyhun Y, Maier M, Mulu A, Diro E, Liebert UG. Hepatitis viruses in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2016;16:1\u201314.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"519_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-019-7885-8","volume":"19","author":"M Adal","year":"2019","unstructured":"Adal M. Systematic review on HIV situation in Addis Ababa, Ethiopia. BMC Public Health. 2019;19(1):1\u201311.","journal-title":"BMC Public Health"},{"issue":"Suppl3","key":"519_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3851\/IMP1621","volume":"15","author":"YF Liaw","year":"2010","unstructured":"Liaw YF, Brunetto MR, Hadziyannis S. The natural history of chronic HBV infection and geographical differences. Antivir Ther. 2010;15(Suppl3):25\u201333.","journal-title":"Antivir Ther"},{"issue":"2","key":"519_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","volume":"11","author":"D Lavanchy","year":"2004","unstructured":"Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepatitis. 2004;11(2):97\u2013107.","journal-title":"J Viral Hepatitis"},{"issue":"12","key":"519_CR20","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","volume":"30","author":"J Ott","year":"2012","unstructured":"Ott J, Stevens G, Groeger J, Wiersma S. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212\u20139.","journal-title":"Vaccine"},{"issue":"5","key":"519_CR21","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/j.1365-2141.2006.06465.x","volume":"136","author":"G Lalazar","year":"2007","unstructured":"Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol. 2007;136(5):699\u2013712.","journal-title":"Br J Haematol"},{"issue":"4","key":"519_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jcv.2007.11.017","volume":"41","author":"S Barclay","year":"2008","unstructured":"Barclay S, Pol S, Mutimer D, Benhamou Y, Mills PR, Hayes PC, et al. The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting. J Clin Virol. 2008;41(4):243\u201354.","journal-title":"J Clin Virol"},{"issue":"1","key":"519_CR23","first-page":"458","volume":"3","author":"JS Sodhi","year":"2015","unstructured":"Sodhi JS, Raja W, Zargar SA, Javid G, Aejaz S, Ahmad M, et al. Screening for occult and overt hepatitis B virus infection in patients of cancer before receiving chemotherapy: looking beyond HBsAg testing. Int J Adv Res. 2015;3(1):458\u201365.","journal-title":"Int J Adv Res"},{"key":"519_CR24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s12072-008-9049-2","volume":"2","author":"YY Dan","year":"2008","unstructured":"Dan YY, Aung MO, Lim SG. The economics of treating chronic hepatitis B in Asia. Hep Intl. 2008;2:284\u201395.","journal-title":"Hep Intl"},{"issue":"1","key":"519_CR25","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1017\/S0950268803008574","volume":"131","author":"A Abebe","year":"2003","unstructured":"Abebe A, Nokes D, Dejene A, Enquselassie F, Messele T, Cutts F. Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control. Epidemiol Infect. 2003;131(1):757\u201370.","journal-title":"Epidemiol Infect"},{"issue":"12","key":"519_CR26","doi-asserted-by":"publisher","first-page":"e0226890","DOI":"10.1371\/journal.pone.0226890","volume":"14","author":"AE Woldegiorgis","year":"2019","unstructured":"Woldegiorgis AE, Erku W, Medhin G, Berhe N, Legesse M. Community-based sero-prevalence of hepatitis B and C infections in South Omo Zone, Southern Ethiopia. PLoS ONE. 2019;14(12):e0226890.","journal-title":"PLoS ONE"},{"key":"519_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2147\/HMER.S374029","volume":"14","author":"A Kumalo","year":"2022","unstructured":"Kumalo A, Teklu T, Demisse T, Anjulo A. Undiagnosed seroprevalence of Hepatitis B and C Virus Infections in the community of Wolaita Zone, Southern Ethiopia. Hepatic Medicine: Evidence and Research. 2022;14:111\u201322.","journal-title":"Hepatic Medicine: Evidence and Research"},{"key":"519_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2147\/IJGM.S259375","volume":"13","author":"AS Belay","year":"2020","unstructured":"Belay AS, Abateneh DD, Yehualashet SS, Kebede KM. Hepatitis B virus infection and associated factors among adults in Southwest Ethiopia: community-based cross-sectional study. Int J Gen Med. 2020;13:323\u201332.","journal-title":"Int J Gen Med"},{"issue":"2","key":"519_CR29","first-page":"1","volume":"2","author":"M Tadesse","year":"2022","unstructured":"Tadesse M, Tafesse G, Hajare ST, Chauhan NM. Assessment of prevalence of Hepatitis B virus and its associated factors among pregnant women from Wolaita Sodo, Ethiopia. J Clin Virol Plus. 2022;2(2):1\u20136.","journal-title":"J Clin Virol Plus"},{"key":"519_CR30","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.2147\/IDR.S380952","volume":"15","author":"M Wondmagegn","year":"2022","unstructured":"Wondmagegn M, Wondimeneh Y, Getaneh A, Ayalew G. Seroprevalence of hepatitis B virus, hepatitis C virus, syphilis and associated factors among female sex workers in Gondar Town, Northwest Ethiopia. Infect Drug Resist. 2022;15:5915\u201327.","journal-title":"Infect Drug Resist"},{"issue":"2","key":"519_CR31","doi-asserted-by":"publisher","first-page":"e0247267","DOI":"10.1371\/journal.pone.0247267","volume":"16","author":"T Tesfa","year":"2021","unstructured":"Tesfa T, Hawulte B, Tolera A, Abate D. Hepatitis B virus infection and associated risk factors among medical students in eastern Ethiopia. PLoS ONE. 2021;16(2):e0247267.","journal-title":"PLoS ONE"},{"issue":"1","key":"519_CR32","first-page":"1","volume":"4","author":"Y Shiferaw","year":"2011","unstructured":"Shiferaw Y, Abebe T, Mihret A. Hepatitis B virus infection among medical waste handlers in Addis Ababa, Ethiopia. BioMed Cent Res Notes. 2011;4(1):1\u20137.","journal-title":"BioMed Cent Res Notes"},{"key":"519_CR33","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.2147\/IDR.S327503","volume":"14","author":"B Getie","year":"2021","unstructured":"Getie B, Ayalew G, Amsalu A, Ferede G, Yismaw G, Tessema B. Seroprevalence and associated factors of hepatitis B and C virus among pulmonary tuberculosis patients attending health facilities in Gondar Town, Northwest Ethiopia. Infect Drug Resist. 2021;14:3599\u2013608.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"519_CR34","first-page":"1718","volume":"9","author":"A Bane","year":"2014","unstructured":"Bane A, Patil A, Khatib M. Healthcare cost and access to care for viral hepatitis in Ethiopia. Int J Innov Appl Stud. 2014;9(4):1718\u201323.","journal-title":"Int J Innov Appl Stud"},{"issue":"9","key":"519_CR35","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","volume":"7","author":"BS Sheena","year":"2022","unstructured":"Sheena BS, Hiebert L, Han H, Ippolito H, Abbasi-Kangevari M, Abbasi-Kangevari Z, et al. Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the global burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7(9):796\u2013829.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"519_CR36","doi-asserted-by":"publisher","first-page":"e1180","DOI":"10.1016\/S2214-109X(19)30272-4","volume":"7","author":"D Tordrup","year":"2019","unstructured":"Tordrup D, Hutin Y, Stenberg K, Lauer JA, Hutton DW, Toy M, et al. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016\u201330. The Lancet Global Health. 2019;7(9):e1180\u2013e8.","journal-title":"The Lancet Global Health"},{"issue":"1","key":"519_CR37","first-page":"3","volume":"18","author":"P Easterbrook","year":"2016","unstructured":"Easterbrook P, Johnson C, Figueroa C, Baggaley R. HIV and hepatitis testing: global progress, challenges, and future directions. AIDS Rev. 2016;18(1):3\u201314.","journal-title":"AIDS Rev"},{"issue":"5","key":"519_CR38","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/cld.1063","volume":"16","author":"MS Odimayo","year":"2020","unstructured":"Odimayo MS, Adebimpe WO, Jeff-Agboola YA, Oyeyemi OT, Okiei BN, Adejumo OA, et al. Screening, vaccination, and referrals as viral Hepatitis elimination Triad among internally displaced persons in Edo state, Nigeria. Clin Liver Disease. 2020;16(5):218\u201322.","journal-title":"Clin Liver Disease"},{"issue":"1","key":"519_CR39","first-page":"1","volume":"16","author":"F Shiferaw","year":"2016","unstructured":"Shiferaw F, Letebo M, Bane A. Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia. BioMed Cent Public Health. 2016;16(1):1\u201313.","journal-title":"BioMed Cent Public Health"},{"issue":"2","key":"519_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00277-010-1055-5","volume":"90","author":"J Kang","year":"2011","unstructured":"Kang J, Cho JH, Suh CW, Lee DH, Oh HB, Sohn YH, et al. High prevalence of hepatitis B and hepatitis C virus infections in korean patients with hematopoietic malignancies. Ann Hematol. 2011;90(2):159\u201364.","journal-title":"Ann Hematol"},{"issue":"1","key":"519_CR41","first-page":"55","volume":"32","author":"AR Omer","year":"2011","unstructured":"Omer AR, Salih JI, Al-Nakshabandi AA. Frequency of blood-borne viral infections among leukemic patients in central Iraq. Saudi Med J. 2011;32(1):55\u201361.","journal-title":"Saudi Med J"},{"issue":"4","key":"519_CR42","first-page":"e18212","volume":"8","author":"M Shaheli","year":"2015","unstructured":"Shaheli M, Yaghobi R, Rezaeian A, Saadi MI, Ramzi M. Study of the associations between TT Virus single and mixed infections with leukemia. Jundishapur J Microbiol. 2015;8(4):e18212.","journal-title":"Jundishapur J Microbiol"},{"issue":"8","key":"519_CR43","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S1473-3099(02)00345-6","volume":"2","author":"M Torbenson","year":"2002","unstructured":"Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis. 2002;2(8):479\u201386.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"519_CR44","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jhep.2008.07.014","volume":"49","author":"G Raimondo","year":"2008","unstructured":"Raimondo G, Allain JP, Brunetto MR, Buendia M-A, Chen D-S, Colombo M, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008;49(4):652\u20137.","journal-title":"J Hepatol"},{"issue":"5","key":"519_CR45","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2008.01.023","volume":"48","author":"G Raimondo","year":"2008","unstructured":"Raimondo G, Navarra G, Mondello S, Costantino L, Colloredo G, Cucinotta E, et al. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol. 2008;48(5):743\u20136.","journal-title":"J Hepatol"},{"issue":"6","key":"519_CR46","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4254\/wjh.v6.i6.384","volume":"6","author":"E Sagnelli","year":"2014","unstructured":"Sagnelli E, Pisaturo M, Martini S, Filippini P, Sagnelli C, Coppola N. Clinical impact of occult hepatitis B virus infection in immunosuppressed patients. World J Hepatol. 2014;6(6):384.","journal-title":"World J Hepatol"},{"key":"519_CR47","first-page":"300","volume":"12","author":"RNCM Jardim","year":"2008","unstructured":"Jardim RNCM, Gon\u00e7ales NSL, Pereira JSF, Fais VC, Gon\u00e7ales Junior FL. Occult hepatitis B virus infection in immunocompromised patients. Brazilian J Infect Dis. 2008;12:300\u20135.","journal-title":"Brazilian J Infect Dis"},{"issue":"2","key":"519_CR48","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00705-016-3111-5","volume":"162","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Zhang Y, Xu N, Huang C, Li X, Li J. High risk of occult hepatitis B virus infection in leukemia patients from China. Arch Virol. 2017;162(2):349\u201357.","journal-title":"Arch Virol"},{"issue":"12","key":"519_CR49","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1007\/s10620-010-1413-0","volume":"55","author":"P Schmeltzer","year":"2010","unstructured":"Schmeltzer P, Sherman KE. Occult hepatitis B: clinical implications and treatment decisions. Dig Dis Sci. 2010;55(12):3328\u201335.","journal-title":"Dig Dis Sci"},{"key":"519_CR50","doi-asserted-by":"crossref","unstructured":"Beykaso G, Mulu A, Giday M, Berhe N, Selamu M, Hailu D et al. Occult Hepatitis B Virus Infection and Its Risks of Cryptic Transmission in Southern Ethiopia. Infection and Drug Resistance. 2022:619 \u2013 30.","DOI":"10.2147\/IDR.S344668"},{"key":"519_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgstr.2022.887260","volume":"1","author":"G Gemechu","year":"2022","unstructured":"Gemechu G, Abagez WE, Alemayehu DH, Tesfaye A, Tadesse D, Kinfu A, et al. Occult hepatitis B virus infection among blood donors in the capital city of Addis Ababa, Ethiopia: implications for blood transfusion safety. Front Gastroenterol. 2022;1:1\u20136.","journal-title":"Front Gastroenterol"},{"issue":"4","key":"519_CR52","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jhep.2010.04.034","volume":"53","author":"J Power","year":"2010","unstructured":"Power J, El Chaar M, Temple J, Thomas M, Spillane D, Candotti D, et al. HBV reactivation after fludarabine chemotherapy identified on investigation of suspected transfusion-transmitted Hepatitis B virus. J Hepatol. 2010;53(4):780\u20137.","journal-title":"J Hepatol"},{"key":"519_CR53","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1590-8658(10)60692-5","volume":"43","author":"C Marinone","year":"2011","unstructured":"Marinone C, Mestriner M. HBV disease: HBsAg carrier and occult B infection reactivation in haematological setting. Dig Liver Disease. 2011;43:49\u2013S56.","journal-title":"Dig Liver Disease"},{"issue":"7","key":"519_CR54","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/hepr.12603","volume":"46","author":"JW Han","year":"2016","unstructured":"Han JW, Yang H, Lee HL, Bae SH, Choi JY, Lee JW, et al. Risk factors and outcomes of hepatitis B virus reactivation in hepatitis B surface antigen negative patients with hematological malignancies. Hepatol Res. 2016;46(7):657\u201368.","journal-title":"Hepatol Res"},{"issue":"7","key":"519_CR55","first-page":"2324","volume":"99","author":"GK Lau","year":"2002","unstructured":"Lau GK, Leung Yh, Fong DY, Au Wy K, Yl, Lie A, et al. High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation. Blood The Journal of the American Society of Hematology. 2002;99(7):2324\u201330.","journal-title":"Blood The Journal of the American Society of Hematology"},{"issue":"1","key":"519_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-016-0090-2","volume":"13","author":"L Weldemhret","year":"2016","unstructured":"Weldemhret L, Asmelash T, Belodu R, Gebreegziabiher D. Sero-prevalence of HBV and associated risk factors among HIV positive individuals attending ART clinic at Mekelle hospital, Tigray, Northern Ethiopia. AIDS Res Therapy. 2016;13(1):1\u20137.","journal-title":"AIDS Res Therapy"},{"issue":"3","key":"519_CR57","doi-asserted-by":"publisher","first-page":"e659","DOI":"10.1002\/hsr2.659","volume":"5","author":"H Mohammed","year":"2022","unstructured":"Mohammed H, Eshetie A, Melese D. Prevalence of hepatitis B virus and associated risk factors among adults patients at Dessie referral and Kemise general hospitals in northeastern Ethiopia. Health Sci Rep. 2022;5(3):e659\u2013e67.","journal-title":"Health Sci Rep"},{"issue":"4","key":"519_CR58","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3934\/medsci.2020023","volume":"7","author":"PN Thanh","year":"2020","unstructured":"Thanh PN, Tho NTT, Phu TD, Dai Quang T, Duong NT, Chien VC, et al. Prevalence and factors associated with chronic Hepatitis B infection among adults in the Central Highland, Vietnam. AIMS Med Sci. 2020;7(4):337\u201346.","journal-title":"AIMS Med Sci"},{"key":"519_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/854530","volume":"2015","author":"M Montella","year":"2015","unstructured":"Montella M, D\u2019Arena G, Crispo A, Capunzo M, Nocerino F, Grimaldi M, et al. Role of sex hormones in the development and progression of hepatitis B virus-associated hepatocellular carcinoma. Int J Endocrinol. 2015;2015:1\u20139.","journal-title":"Int J Endocrinol"},{"issue":"2","key":"519_CR60","doi-asserted-by":"publisher","first-page":"e1005374","DOI":"10.1371\/journal.ppat.1005374","volume":"12","author":"LG Vom Steeg","year":"2016","unstructured":"Vom Steeg LG, Klein SL. SeXX matters in infectious disease pathogenesis. PLoS Pathog. 2016;12(2):e1005374.","journal-title":"PLoS Pathog"},{"issue":"10","key":"519_CR61","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626\u201338.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"519_CR62","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/nri2394","volume":"8","author":"EN Fish","year":"2008","unstructured":"Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol. 2008;8(9):737\u201344.","journal-title":"Nat Rev Immunol"},{"key":"519_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.01184","volume":"11","author":"I Ben-Batalla","year":"2020","unstructured":"Ben-Batalla I, Vargas-Delgado ME, Von Amsberg G, Janning M, Loges S. Influence of androgens on immunity to self and foreign: effects on immunity and cancer. Front Immunol. 2020;11:1\u201320.","journal-title":"Front Immunol"},{"issue":"5834","key":"519_CR64","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1126\/science.1140485","volume":"317","author":"WE Naugler","year":"2007","unstructured":"Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317(5834):121\u20134.","journal-title":"Science"},{"issue":"8","key":"519_CR65","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/jgh.12934","volume":"30","author":"SH Wang","year":"2015","unstructured":"Wang SH, Chen PJ, Yeh SH. Gender disparity in chronic hepatitis B: mechanisms of sex hormones. J Gastroenterol Hepatol. 2015;30(8):1237\u201345.","journal-title":"J Gastroenterol Hepatol"},{"key":"519_CR66","first-page":"86","volume":"14","author":"N Benedict","year":"2015","unstructured":"Benedict N, Samson AA. Seroprevalence of HBV, HCV and HIV infection in patients with haematological malignancies seen at the university of Benin Teaching Hospital, Benin City, Nigeria. IOSR J Dent Med Sci. 2015;14:86\u201391.","journal-title":"IOSR J Dent Med Sci"},{"issue":"3","key":"519_CR67","first-page":"183","volume":"21","author":"D Mbanya","year":"2002","unstructured":"Mbanya D, Mikoulou E, Kaptue L. HIV-1 infection in adults with haematological malignancies in Yaounde, Cameroon. West Afr J Med. 2002;21(3):183\u20134.","journal-title":"West Afr J Med"},{"key":"519_CR68","doi-asserted-by":"crossref","unstructured":"Fentaye S, Yibeltal D, Tessema Z. Prevalence of HIV\/AIDS Among Elderly People and Associated Factors in Habru Woreda, Amhara Region, Northeast Ethiopia. HIV\/AIDS-Research and Palliative Care. 2020;2020:411 \u2013 23.","DOI":"10.2147\/HIV.S265101"},{"key":"519_CR69","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/HMER.S365443","volume":"2022","author":"Y Tassachew","year":"2022","unstructured":"Tassachew Y, Abebe T, Belyhun Y, Teffera T, Shewaye AB, Desalegn H, et al. Prevalence of HIV and its co-infection with hepatitis B\/C virus among chronic liver disease patients in Ethiopia. Hepatic Medicine: Evidence and Research. 2022;2022:67\u201377.","journal-title":"Hepatic Medicine: Evidence and Research"},{"key":"519_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13690-018-0299-8","volume":"76","author":"T Girum","year":"2018","unstructured":"Girum T, Wasie A, Lentiro K, Muktar E, Shumbej T, Difer M, et al. Gender disparity in epidemiological trend of HIV\/AIDS infection and treatment in Ethiopia. Archives of Public Health. 2018;76:1\u201310.","journal-title":"Archives of Public Health"},{"issue":"2","key":"519_CR71","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/073993302753429031","volume":"23","author":"L Ackermann","year":"2002","unstructured":"Ackermann L, Klerk GW. Social factors that make south african women vulnerable to HIV infection. Health Care Women Int. 2002;23(2):163\u201372.","journal-title":"Health Care Women Int"},{"issue":"3","key":"519_CR72","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/sti.2010.047514","volume":"87","author":"SC Kalichman","year":"2011","unstructured":"Kalichman SC, Pellowski J, Turner C. Prevalence of sexually transmitted co-infections in people living with HIV\/AIDS: systematic review with implications for using HIV treatments for prevention. Sex Transm Infect. 2011;87(3):183\u201390.","journal-title":"Sex Transm Infect"},{"issue":"4","key":"519_CR73","doi-asserted-by":"publisher","first-page":"435","DOI":"10.4269\/ajtmh.1993.49.435","volume":"49","author":"D Frommel","year":"1993","unstructured":"Frommel D, Teklehaimanot R, Berhe N, Aussel L, Verdier M, Preux PM, et al. A survey of antibodies to hepatitis C virus in Ethiopia. Am J Trop Med Hyg. 1993;49(4):435\u20139.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"519_CR74","first-page":"1","volume":"21","author":"Y Zenebe","year":"2015","unstructured":"Zenebe Y, Mulu W, Yimer M, Abera B. Sero-prevalence and risk factors of hepatitis C virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: cross sectional study. Pan Afr Med J. 2015;21(1):1\u20134.","journal-title":"Pan Afr Med J"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-023-00519-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-023-00519-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-023-00519-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T17:03:15Z","timestamp":1689181395000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-023-00519-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["519"],"URL":"https:\/\/doi.org\/10.1186\/s13027-023-00519-6","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,12]]},"assertion":[{"value":"12 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Research Board of Aklilu Lemma Institute of pathobiology Addis Ababa University\/Ref No. ALIPB IRB\/009\/2011\/2018, College of Health Science Addis Ababa University (CHS IRB) Protocol number: 001\/19\/IM, AHRI\/ALERT Ethics Review Committee (AAERC) Protocol No.PO34\/18 and Consent \/assent were obtained from participants or their families\/caregiver. Confidentiality was maintained throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}